Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 35%
Buy 30%
Hold 30%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is well-positioned with a substantial presence in the fastest-growing markets in the United States, along with having a leading position in primary urban markets and a diverse business mix. The company's efforts in sustainability, including significant reductions in construction waste, energy use, and water consumption, also bode well for its long-term future. Despite recent headwinds from respiratory illness and unfavorable weather, the company's core growth trends are expected to improve in the second half of 2026 and remain consistent with its original plans, supporting a positive outlook from analysts and a "buy" rating with a price target of $535 per share.

Bears say

HCA Healthcare is likely to struggle in the near-term due to lower hospital volume and mix, as well as higher competition in the market and challenges related to reimbursement from government healthcare programs. Additionally, supply shortages in certain markets could impact productivity and margins. While the company has a strong track record of operational performance, investors may want to exercise caution in the face of these current headwinds.

HCA Healthcare (HCA) has been analyzed by 20 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 30% recommend Buy, 30% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 20 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $477.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $477.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.